TheEdgeResearch
Home / Stocks / CRYM

Cryomass Technologies Inc. (CRYM)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +0.00%
Market Cap
$47,432
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
-0.18
52-Wk Range
0.0001-0.01
CEO
Christian Noel
Country
US
Currency
USD

Cryomass Technologies Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Denver, CO, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $47,432. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -95602.1%. Its beta of -0.18 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.00
Price / Sales
3.50
Price / Book
-0.01
EV / EBITDA
-0.37
Gross margin
100.0%
Operating margin
-79560.2%
Net margin
-95602.1%
Return on equity
Debt / equity
-0.77
Current ratio
0.06
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
6
IPO date
2014-06-02
Headquarters
Denver, CO, US
About Cryomass Technologies Inc.

Cryomass Technologies Inc., established in 2011 and based in Denver, Colorado, specializes in the development, distribution, and commercialization of cryo-mechanical systems. These systems are specifically engineered for processing freshly harvested hemp, cannabis, and other premium botanical materials. The company rebranded to its current name in August 2021, having previously operated as Andina Gold Corp.

Comparable companies

Cryomass Technologies Inc. is most often compared with the following Healthcare names:

GENPFIGEXKAYSKOANLVVVMCOANRPRRDDTFRNUGFTLLTF
More research on CRYM
CRYM technical analysis CRYM TheEdge Score Compare against peers
Open full interactive analysis & DCF →